Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SGMS2 | Q8NHU3 | 8/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | HPGD | P15428 | 3/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | ELANE | P08246 | 1/20 | 0.51 |
| ▸ | MAOB | P27338 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | F2 | P00734 | 1/20 | 0.46 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.45 |
| ▸ | DHODH | Q02127 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 2/20 | 0.44 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.44 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.44 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13998685 | 0.91 | ALDH1A1 (0.59) | SGMS2ALDH1A1KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL23458473 | 0.87 | ALDH1A1 (0.53) | SGMS2ALDH1A1KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL13998715 | 0.87 | HPGD (0.57) | SGMS2ALDH1A1KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL13052998 | 0.87 | ALDH1A1 (0.52) | SGMS2ALDH1A1KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL27424133 | 0.87 | ALDH1A1 (0.48) | SGMS2ALDH1A1KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL27424623 | 0.86 | NPC1 (0.50) | SGMS2ALDH1A1KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL29184540 | 0.86 | HPGD (0.60) | SGMS2ALDH1A1KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL12910410 | 0.86 | HPGD (0.56) | SGMS2ALDH1A1KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL27423331 | 0.85 | NPC1 (0.49) | SGMS2ALDH1A1KDM4EHPGDSMN1; SMN2 | |
| SCHEMBL27424130 | 0.85 | NPC1 (0.49) | SGMS2ALDH1A1KDM4EHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357188-A1 | PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF | WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) | 2023-11-09 | — | — | US | disclosed |
| US-20230357188-A1 | PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF | WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) | 2023-11-09 | — | — | US | disclosed |
| US-20230250118-A1 | ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-08-10 | — | — | US | disclosed |
| US-20230144101-A1 | LIGHT-EMITTING MATERIAL WITH A POLYCYCLIC LIGAND | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2023-05-11 | — | — | US | disclosed |
| US-20220402877-A1 | ELECTROLUMINESCENT DEVICE | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2022-12-22 | — | — | US | disclosed |
| US-5077408-A | PROCESS FOR THE SYNTHESIS OF OXAZOLOPYRIDINE COMPOUNDS | SCIENCE ET ORGANISATION (FR) | 1991-12-31 | — | — | US | disclosed |
| US-5061713-A | NO ANTIINFLAMMATORY ACTIVITY | SCIENCE ET ORGANIZATION (FR) | 1991-10-29 | — | — | US | disclosed |
| US-4131677-A | Anti-inflammatory oxazolo [5,4-b]pyridines | MERCK & CO., INC. (US) | 1978-12-26 | — | — | US | disclosed |
| US-4038396-A | ANTIPYRETICS, ANALGESICS | MERCK & CO., INC. (US) | 1977-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220402877-A1 | ELECTROLUMINESCENT DEVICE | MCOLN2, MCOLN1, LDHB | SGMS2 3703/4885ALDH1A1 851/4885KDM4E 1211/4885 |
| US-20230357188-A1 | PHENANTHRENE ORGANIC COMPOUND AND USE THEREOF | AHR, ORAI3, WNT3 | SGMS2 4400/4885ALDH1A1 1797/4885KDM4E 3942/4885 |
| US-20230250118-A1 | ELECTROLUMINESCENT MATERIAL AND DEVICE THEREOF | CRY1, LEF1, PIEZO1 | SGMS2 4535/4885ALDH1A1 500/4885KDM4E 743/4885 |
| US-20230144101-A1 | LIGHT-EMITTING MATERIAL WITH A POLYCYCLIC LIGAND | TRPC4, CRY1, TRPC1 | SGMS2 4325/4885ALDH1A1 2910/4885KDM4E 1963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.